Equasens (FRA:PHF) Moat Score: 0/10 (As of Jul. 03, 2026)


FRA:PHF Equasens FRA:PHF
93 GF Score
Price €52.77
GF Value €85.23
! 2 Warning Signs
View Full Analysis

What is Equasens Moat Score?

Equasens has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Equasens has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Equasens might have No Moat - No discernible moat.

Equasens  (FRA:PHF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Equasens Moat Score Related Terms

FRA:PHF
93GF Score
Equasens FRA:PHF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Equasens (FRA:PHF) Overvalued in 2026?

Based on GuruFocus' analysis, Equasens stock appears to be undervalued. The current stock price of €52.77 is trading 38.1% below its estimated GF Value™ of €85.23.

Key valuation signals for FRA:PHF:

  • Moat Score: 0
  • GF Value™: €85.23 vs. price of €52.77 (38.1% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the FRA:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Equasens Business Description

Address 5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
93GF Score

Get the complete analysis for FRA:PHF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€52.77
Price
€85.23
GF Value